AVANOS MEDICAL - IRVINE HOMEPUMP C-SERIES, 270 ML, 5 ML/HR (CONTAINS DEHP); ELASTOMERIC LFR
|
Back to Search Results |
|
Model Number C270050 |
Device Problem
Improper Flow or Infusion (2954)
|
Patient Problems
Nausea (1970); Rash (2033)
|
Event Date 03/12/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
The actual complaint product was not returned for evaluation.The device history record for the reported lot number, 0202620030, in this complaint was reviewed and the material was produced according to the manufacturing procedures and met the quality requirements.All information reasonably known as of 18-apr-2019 has been included in this health authority report.Should additional information be obtained, a follow-up health authority report will be provided.Avanos medical, inc.Has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the avanos medical, inc.Complaint database and identified as complaint (b)(4).
|
|
Event Description
|
Fill volume: 241 ml, flow rate: 5ml/hr, procedure: unknown, cathplace: unknown, start date: 5:15 pm on (b)(6) 2019.It was reported the homepump was started on (b)(6) 2019 and was to infuse for 46-hours.On (b)(6) 2019 at approximately 9:00 pm the patient reported the device was empty.At 10:00pm the nursing team verified that the device was empty and the infusion was completed.The infusion was expected to be completed approximately at 3:15 pm; however, the patient reported that the infusion ended the night before.On (b)(6) 2019 the clinicians were unable to specify the exact time the infusion was completed, since it occurred before the patient arrived at the clinic.There was no reported injury and the patient was noted to be doing "good." additional information received (b)(6) 2019 stated the device tubing was kept under patient a blanket.The patient reported nausea and skin rash; however, the pharmacist noted that the patient started to use oral isosorbide during the chemotherapy intravenous (iv) infusion protocols.
|
|
Search Alerts/Recalls
|
|
|